Skip to main content
Premium Trial:

Request an Annual Quote

NeoGenesis, Tranzyme Expand Therapeutic Discovery Collaboration

NEW YORK, Nov. 25 (GenomeWeb News) - Tranzyme and NeoGenesis Pharmaceuticals said today that they have expanded a therapeutic discovery collaboration that began in August 2001.

Under the expanded collaboration, NeoGenesis will provide additional sets of disease-associated gene sequences of therapeutic interest, and Tranzyme will deliver these genes into different mammalian cell lines and express the proteins using its protein expression technology TExT (Trans Expression Technology). NeoGenesis will use the purified proteins in its ALIS (Automated Ligand Identification System) high-capacity screening platform to discover novel leads for therapeutic intervention.

Further terms of the collaboration were not disclosed.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.